SBIR/STTR Research Award

SBIR Phase I: Antimicrobial Nanocoatings through Grafting of PECVD Films

Award identifier d1ea648cfc8056191ad274b794b8a146ad52632674beca71dc9e2c64aa2a429cAwarding agency National Science Foundation

Award amount

$99,680

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
BRIGHTON TECHNOLOGIES GROUP, INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
RLV1WRJF1SK3
Solicitation number
Not reported
Topic code
Not reported

Research abstract

This Small Business Innovation Research Phase I project aims to develop a novel process onto a variety of surfaces. Effective integration of ionic silver into the coating remains a difficult engineering challenge due to low precursor volatility and ionic metal ligand instability. The proposed development of a commercially viable AMNC process will include: 1)Deposition of nanometer-scale films via PECVD that contain leachable silver ions, synthesized with at least two different matrix polymers (organic and inorganic) and a range of silver content. This will be accomplished via post-deposition grafting of silver containing organometallics onto PECVD plasma polymers. 2) Establishing antimicrobial effectiveness of these silver-containing PECVD films as a function of structure and composition. Film composition, thickness, and morphology are all controllable by suitable choice of reactant gases and deposition conditions. A successful Phase I project will result in the demonstration of a nanometer-scale antimicrobial coating that has been tested on a panel of approximately 20 of the top bacterial pathogens. Commercially AMNCs are not currently available on the market. Thinner than the razor edge of a scalpel and nearly invisible, AMNCs offer distinct advantages over available thick antimicrobial paints while addressing important problems such as nosocomial (hospital acquired) infections (NI). NIs represent one of the most severe problems facing the health care industry. The CDC estimates that NIs cause over 100,000 deaths per year in the U.S. alone, with a concomitant increased health care cost of over 5 billion dollars per year. Contaminated hands are believed to be the single greatest cause of transmitting NIs. Applying AMNCs to hand contact surfaces (e.g. door knobs, bathroom fixtures) in facilities such as hospitals and public schools could be tremendously beneficial. Moreover, AMNCs can enhance healthcare by improving microbial and biofilm resistance of medical materials (e.g. indwelling catheters, central lines, prostheses, other invasive devices).

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

11 SBIR/STTR records share this UEI (1996–2015). Reported award amounts total $3,401,325. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: National Science Foundation, Environmental Protection Agency, Department of Health and Human Services, Department of Defense

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.